Colosia A, Njue A, Bajwa Z, Dragon E, Robinson RL, Sheffield KM, Thakkar S, Richeimer SH. The burden of metastatic cancer-induced bone pain: a narrative review. J Pain Res. 2022 Oct 25;2022(15):3399-412. doi: 10.2147/JPR.S371337
Iyer S, Candrilli SD, Davis KL. Patterns of opioid use, opioid-related side effects and resource utilization in cancer patients on chronic opioid therapy with constipation versus matched controls without constipation. Poster presented at the Scientific Symposium of the National Hospice and Palliative Care Organization; November 2007.
Hutchison RW, Anastassopoulos K, Vallow S, Mordin M, Olson W, Hewitt D, Sikirica V. Intravenous patient-controlled analgesia pump and reservoir logistics: results from a multicenter questionnaire. Hosp Pharm. 2007 Nov 1;42(11):1036-44.
Candrilli SD, Iyer S, Davis KL. Impact of constipation on health care utilization and costs in patients on opioid therapy. Poster presented at the 2007 ISPOR 10th Annual European Congress; October 2007. Dublin, Ireland.
Davis KL, Candrilli SD, Iyer S. Impact of constipation on resource utilization and costs in non-metastatic cancer patients on opioid therapy. Poster presented at the Annual Clinical Meeting of the American Academy of Pain Management; September 2007.
Barrett AM, Lucero MA, Le T, Robinson RL, Dworkin RH, Chappell AS. Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: a review. Pain Med. 2007 Sep 1;8(Suppl 2):S50-62.
Iyer S, Candrilli SD, Davis KL. Opioid use patterns, health care utilization, and costs in metastatic cancer patients on chronic opioid therapy with constipation compared to patients without constipation. Poster presented at the 14th European Cancer Conference; September 2007.
Midkiff K, Johannes CB, Mohan AK. Strengths and limitations of drug abuse warning network data used in a surveillance study. Poster presented at the 23rd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 23, 2007. Quebec City, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2007 Aug; 16(S1-274):S234.
Mordin M, Anastassopoulos K, van Breda A, Vallow S, Zhang M, Gargiulo K, Hewitt D, Olson W, Sikirica V. Clinical staff resource use with intravenous patient-controlled analgesia in acute postoperative pain management: results from a multicenter, prospective, observational study. J Perianesth Nurs. 2007 Aug 1;22(4):243-55.
Cook SF, Bell T, Sweeney CT, Fehnel SE, Hollis KA. Impact on quality of life of constipation associated gi symptoms related to opioid treatment in chronic pain patients: pAC-QoL results from the opioid survey. Poster presented at the 26th Annual Scientific Meeting of the American Pain Society; May 2007.
Cook SF, Bell TJ, Sweeney CT, Goss DS, Zhou X. Severity of constipation-associated gi symptoms related to opioid treatment in chronic pain patients: pac-sym questionnaire results from the opioid survey. Poster presented at the 26th Annual Scientific Meeting of the American Pain Society; May 2007.
Perez-Gutthann S, Garcia-Rodriguez LA, Duque-Oliart A, Varas-Lorenzo C. Low-dose diclofenac, naproxen, and ibuprofen cohort study. Pharmacotherapy. 1999 Jul 1;19(7):854-9. doi: 10.1592/phco.19.10.854.31550
Neighbors DM, Bell T, Wilson TJ, Dodd SL. A three-phased decision analytic model for the economic evaluation of opioid therapy for chronic pain. Poster presented at the 1999 ISPOR 4th Annual International Meeting; May 1999. Arlington, VA.
Rosen JB, Granger AL, Walker EA. Nalbuphine drug discriminations: effects of opioid peptide ctap. Poster presented at the 1st International Meeting of the Behavioral Pharmacology Society and European Behavioral Pharmacology Society; 1999.
Rothman KJ, Wepsic JG. Side of facial pain in trigeminal neuralgia. J Neurosurg. 1974 Jan 1;40(4):514-6.